First-degree atrioventricular block is associated with advanced atrioventricular block, atrial fibrillation and left

Jae-Sun Uhm1, Jaemin Shim, Jin Wi

  • 1Division of Cardiology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.

Insights

First-degree atrioventricular block (AVB) in hypertensive patients indicates a higher risk for advanced AVB, atrial fibrillation, and left ventricular dysfunction. This finding highlights the clinical significance of monitoring PR intervals in hypertension management.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Hypertension Research

Background:

  • First-degree atrioventricular block (AVB) is common in hypertensive individuals.
  • The long-term prognostic implications of first-degree AVB in this population remain unclear.
  • Understanding these risks is crucial for effective hypertension management and cardiovascular risk stratification.

Purpose of the Study:

  • To investigate the long-term prognosis of first-degree AVB in patients with hypertension.
  • To determine if first-degree AVB is an independent risk factor for adverse cardiovascular outcomes.
  • To compare the incidence of advanced AVB, sick sinus syndrome, atrial fibrillation, and left ventricular dysfunction between hypertensive patients with and without first-degree AVB.

Main Methods:

  • A cohort of 3816 hypertensive patients was analyzed.
  • Patients were categorized based on PR interval duration: normal (120-200 ms) versus first-degree AVB (>200 ms).
  • Electrocardiograms were reviewed, and outcomes including advanced AVB, sick sinus syndrome, atrial fibrillation, and left ventricular dysfunction were tracked over a mean follow-up of 9.4 years.

Main Results:

  • First-degree AVB was present in 14.3% of the hypertensive patients.
  • Patients with first-degree AVB showed significantly higher cumulative incidence of advanced AVB, atrial fibrillation, and left ventricular dysfunction.
  • Multivariate analysis confirmed first-degree AVB as an independent risk factor for advanced AVB (HR 2.77), atrial fibrillation (HR 2.33), and left ventricular dysfunction (HR 1.49). Sick sinus syndrome was not associated.

Conclusions:

  • First-degree AVB is a significant independent risk factor in hypertensive patients.
  • It predicts the future development of advanced AVB, atrial fibrillation, and left ventricular dysfunction.
  • Routine ECG monitoring for PR interval prolongation is recommended for hypertensive patients to identify those at higher cardiovascular risk.
Abstract

Related Concept Videos

Dysrhythmias IV: Characteristics of Bradyarrhythmias01:18

Dysrhythmias IV: Characteristics of Bradyarrhythmias

Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
788
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
5.3K
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
2.7K
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
1.2K
Adrenergic Antagonists: ɑ and β-Receptor Blockers01:31

Adrenergic Antagonists: ɑ and β-Receptor Blockers

Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
1.4K
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
2.8K